MidEuropa has signed an agreement to acquire a controlling stake in Famar, a pharmaceutical contract development and manufacturing organization (CDMO), from ECM Partners and Metric Capital Partners. MidEuropa will invest alongside the management team and current shareholders, who will retain a minority stake. The transaction, which is subject to customary anti-trust and regulatory approvals, is expected to close in the second half of 2024. Famar provides a full-service offering across th...